Um Biosortia pharmaceuticals

Über das Unternehmen

Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics. It has the only capability in the world to obtain the long-sought, but previously unobtainable drug-like molecules directly from the microbiome. The company was founded in 2012 and is headquartered in San Diego, California.